ltrafast diagnosis of epilepsy: a randomised controlled trial of AI-assisted interpretation of ambulatory EEG recordings versus routine care.
- Conditions
- Epilepsy10039911
- Registration Number
- NL-OMON56882
- Lead Sponsor
- Medisch Spectrum Twente
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 62
Inclusion Criteria
- The participant must be an adult (>=18 years).
- The participant is referred for a routine EEG with the differential diagnosis
of epilepsy.
Exclusion Criteria
- Patients with cognitive impairments that limits patients* understanding of
the research purpose and to give informed consent.
- Patients who previously have been diagnosed with epilepsy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The main study parameter is the time-to-diagnosis, defined as the time (in<br /><br>weeks) from initial referral to final diagnosis of epilepsy.</p><br>
- Secondary Outcome Measures
Name Time Method <p>- Total cost of each study arm.<br /><br>- Time spend by medical professionals reviewing the EEGs.<br /><br>- Sensitivity, specificity and F1 score of routine EEG and ambulatory EEG with<br /><br>AI.<br /><br>- Patient satisfaction score measured by the patient satisfaction questionnaire.<br /><br>- Time patients invested in the diagnostic process of both study arms.</p><br>